Publications by authors named "Jeffrey A Handler"

Claim this Profile
T
The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetes.
Alexander R Ochman, Christopher A Lipinski, Jeffrey A Handler, Andrew G Reaume, Michael S Saporito

J Pharmacol Exp Ther· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MLR-1023 is a potent and selective allosteric activator of Lyn kinase in vitro that improves glucose tolerance in vivo.
Michael S Saporito, Alexander R Ochman, Christopher A Lipinski, Jeffrey A Handler, Andrew G Reaume

J Pharmacol Exp Ther· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis